Salud financiera de hoja de balance de Hester Biosciences
Salud financiera controles de criterios 2/6
Hester Biosciences tiene un patrimonio de accionistas total de ₹3.0B y una deuda total de ₹2.4B, lo que sitúa su ratio deuda-patrimonio en 80.7%. Sus activos y pasivos totales son ₹6.6B y ₹3.6B respectivamente. El BAIT de Hester Biosciences es de ₹477.6M, por lo que su ratio de cobertura de intereses es de 4.9. Tiene efectivo e inversiones a corto plazo que ascienden a ₹153.0M.
Información clave
80.7%
Ratio deuda-patrimonio
₹2.44b
Deuda
| Ratio de cobertura de intereses | 4.9x |
| Efectivo | ₹153.04m |
| Patrimonio | ₹3.03b |
| Total pasivo | ₹3.59b |
| Activos totales | ₹6.62b |
Actualizaciones recientes sobre salud financiera
These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Nov 25
These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Aug 25
Recent updates
Hester Biosciences Limited's (NSE:HESTERBIO) CEO Compensation Looks Acceptable To Us And Here's Why
Aug 23What Hester Biosciences Limited's (NSE:HESTERBIO) 26% Share Price Gain Is Not Telling You
Jul 27Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price
Jun 12Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00
Aug 01Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?
Mar 03Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?
Feb 13What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?
Jan 26Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Jan 11Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 25Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 10These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Nov 25How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?
Nov 10If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns
Oct 26What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?
Oct 05Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?
Sep 14These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively
Aug 25How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?
Aug 07Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?
Jul 07Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹2.1B) de HESTERBIO superan a sus pasivos a corto plazo (₹1.1B).
Pasivo a largo plazo: Los activos a corto plazo (₹2.1B) de HESTERBIO no cubren sus pasivos a largo plazo (₹2.5B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de HESTERBIO (88.8%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de HESTERBIO ha crecido de 49.6% a 80.7% en los últimos 5 años.
Cobertura de la deuda: La deuda de HESTERBIO no está bien cubierta por el flujo de caja operativo (19.7%).
Cobertura de intereses: Los pagos de intereses de la deuda de HESTERBIO están bien cubiertos por el BAIT (6x cobertura).